To the Editor: In their 2010 guidelines, the International AIDS Society–USA panel reinforced the recommendation to initiate combination antiretroviral treatment (cART) in individuals infected with human immunodeficiency virus (HIV) with rapid CD4 cell count decline of greater than 100/μL per year (level of evidence rating AIIa).1,2 In so doing, the panel ignored recent evidence from the large CASCADE collaboration of a lack of association between the pretreatment CD4 cell slope and the hazards of AIDS and death in ART-naive patients.3
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 7
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.